Search the Newsreel

Integral Diagnostics Says Fiscal 2026 Revenue, Net Profit After Tax Expected to Jump

Integral Diagnostics Posts Strong FY2026 Growth Forecast

Integral Diagnostics: FY26 results and new CFO appointment

Integral Diagnostics Limited Provides Preliminary Earnings Guidance for the Year 2026

Integral Diagnostics (ASX:IDX): Can Merger Synergies Support the Next Growth Phase?

GRAIL Inc Revenue Breakdown – LSX:A40F8M

GRAIL Inc (LSX:A40F8M) generated 125.31 million EUR in revenue last year. The majority of this revenue, 118.01 million EUR, came from its top-performing "Screening" segment, an increase from 104.93 million EUR in the previous year. The United States was the largest geographical contributor, accounting …

GRAIL (GRAL) Stock Sinks As Cash Burn Drowns Galleri Growth

GRAIL Inc (GRAL) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...

This article first appeared on GuruFocus. Total Revenue: $44.7 million, up 26% year over year. Screening Revenue: $42.6 million, up 24% year over year. Development Services Revenue: $2 million. Test Volume: Over 61,000 Galleri tests sold, a 35% increase year over year. First Half …

GRAIL (Nasdaq: GRAL) Q2 revenue rises 26% as net loss narrows

Integral Diagnostics Limited (ASX: IDX): Potential Inverse Head & Shoulders Breakout Signals Medium-Term Recovery

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026

Faruqi & Faruqi, LLP is investigating potential securities claims against Grail, Inc. (NASDAQ: GRAL) and reminds investors that the deadline to seek the role of lead plaintiff in a federal securities class action lawsuit is August 4, 2026. The lawsuit alleges that Grail made …

Portnoy Law Firm Announces Class Action on Behalf of Grail, Inc. Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in Grail, Inc. (NASDAQ: GRAL) who purchased securities between May 13, 2025, and February 19, 2026. The lawsuit alleges that Grail made misleading statements and concealed material adverse facts regarding …

GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL), urging investors with substantial losses to join before the August 4, 2026, lead plaintiff deadline. The lawsuit alleges that GRAIL and its executives misled investors about …

GRAL FINAL DEADLINE ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline

SAN FRANCISCO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in GRAIL, Inc. (NASDAQ: GRAL) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses to submit your losses …

Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?

Key Points Grail’s stock crashed after Galleri’s NHS England trial missed its primary endpoint. But it’s still generating plenty of revenue without an FDA approval.10 stocks we like better than Grail › Grail (NASDAQ: GRAL), which was spun off from Illumina (NASDAQ: ILMN) in …

GRAL DEADLINE TUESDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 4 Deadline in Securities Class Action – GRAL

NEW YORK, Aug. 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”), of the important August …

המועד האחרון לתביעה הייצוגית נגד GRAL ביום שלישי: רוזן, יועץ למשקיעים מיומן, מעודד את משקיעי GRAIL, Inc. עם הפסדים של מעל 100,000$ להשיג ייצוג משפטי לפני המועד האחרון החשוב ב-4 באוגוסט בתביעה ייצוגית בניירות ערך – GRAL

ניו יורק, Aug. 01, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשי המניות הרגילות של GRAIL, Inc. (נאסד"ק: GRAL) בין התאריכים 13במאי 2025 עד 19בפברואר 2026, שני התאריכים כוללים ("תקופת התביעה …

Why Is Integral Diagnostics (ASX:IDX) in Focus?

$GRAL Securities: Suffer Losses on Your GRAIL, Inc.

Bleichmar Fonti & Auld LLP has filed a class action lawsuit against GRAIL, Inc. (NASDAQ:GRAL) and its executives for securities fraud. The lawsuit alleges that GRAIL misled investors regarding its NHS-Galleri cancer trial, causing a 50% stock drop after the trial failed to meet …

GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference

GRAIL (Nasdaq: GRAL) announced that its management will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on Tuesday, August 11, at 10:00 a.m. ET. Live and replay webcasts of the presentation will be available through GRAIL's investor relations website, with the …

GRAL Deadline: Rosen Law Firm Urges GRAIL, Inc. (NASDAQ: GRAL) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm is notifying stockholders of GRAIL, Inc. (NASDAQ: GRAL) about a class action lawsuit for alleged misleading statements made between May 13, 2025, and February 19, 2026. The lawsuit claims GRAIL concealed material adverse facts regarding its NHS-Galleri trial's sufficiency to demonstrate …

Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL) alleging violations of federal securities laws. The lawsuit claims that Grail and its officers made false and misleading statements regarding the likelihood of achieving the primary endpoint in …

Levi & Korsinsky Reminds Grail, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 4, 2026 - GRAL

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Grail, Inc. (NASDAQ: GRAL), reminding investors who purchased stock between May 13, 2025, and February 19, 2026, of the August 4, 2026 lead plaintiff deadline. The lawsuit alleges that Grail's leadership withheld …

Epigral Limited schedules one-on-one meeting with VVD Asset Managers

Epigral net profit rises 25% to ₹99 crore in Q1FY27

GRAIL to Announce Second Quarter 2026 Financial Results

GRAIL, Inc. (Nasdaq: GRAL) announced it will release its second-quarter 2026 financial results after market close on Wednesday, August 5, 2026. Following the release, company management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the …

Bragar Eagel & Squire, P.C. Reminds GRAIL, Inc. Investors They Have Until August 4th to Contact the Firm Seeking Lead Plaintiff Rol

Bragar Eagel & Squire, P.C. has announced a class action lawsuit against GRAIL, Inc. (NASDAQ:GRAL) for allegedly making false and misleading statements regarding its NHS Galleri trial. Investors who purchased GRAIL common stock between May 13, 2025, and February 19, 2026, and suffered losses …

GRAIL webcast on Aug. 5 results open to all interested parties

GRAIL (Nasdaq: GRAL) will announce its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Following the release, company management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and …

GRAL INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of the August 4, 2026 Lead Plaintiff Deadline in the Grail, Inc. Securities Class Action

ATLANTA, July 29, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Grail, Inc. (“Grail”) (NASDAQ: GRAL). The lawsuit alleges that Defendants made false and misleading statements and/or failed to disclose material adverse facts regarding the probability of achieving the …

TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Grail Class Action Lawsuit - GRAL

SAN DIEGO, July 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of GRAIL, Inc. (NASDAQ: GRAL) common stock between May 13, 2025 and February 19, 2026, both dates inclusive (the “Class Period”), …

GRAIL, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 4, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds GRAIL, Inc. (“GRAIL” or the “Company”) (NASDAQ: GRAL) investors of the August 4, 2026 deadline involving a securities fraud class action lawsuit commenced against the …

GRAL Court Deadline: GRAIL, Inc. Investor Deadline in Securities Fraud Class Action is August 4 – Contact BFA Law if You Lost Money

Bleichmar Fonti & Auld LLP has announced a securities fraud class action lawsuit against GRAIL, Inc. (NASDAQ:GRAL) and its executives. The lawsuit alleges that GRAIL misled investors regarding its NHS-Galleri cancer trial, which caused a 50.55% stock drop on February 20, 2026, after the …

Epigral net profit falls 38% YoY as input costs rise